Individualized antibiotic dosage regimens for patients with augmented renal clearance

被引:14
作者
Shi, A-Xi [1 ,2 ]
Qu, Qiang [3 ,4 ,5 ]
Zhuang, Hai-Hui [1 ]
Teng, Xin-Qi [1 ]
Xu, Wei-Xin [1 ]
Liu, Yi-Ping [1 ]
Xiao, Yi-Wen [1 ]
Qu, Jian [1 ,5 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Inst Clin Pharm, Dept Pharm, Changsha, Peoples R China
[2] First Hosp Lanzhou Univ, Dept Pharm, Lanzhou, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[5] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Changsha, Peoples R China
关键词
augmented renal clearance; antibiotic; pharmacokinetics; pharmacodynamics; individualized; CRITICALLY-ILL PATIENTS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS INFECTIONS; VITRO ANTIMICROBIAL ACTIVITY; AMOXICILLIN-CLAVULANIC ACID; MONTE-CARLO-SIMULATION; POPULATION PHARMACOKINETICS; ANTIBACTERIAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; CREATININE CLEARANCE;
D O I
10.3389/fphar.2023.1137975
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%-65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes.Methods: We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC.Results: 25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research.Conclusion: ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.
引用
收藏
页数:14
相关论文
共 177 条
  • [61] Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen Susceptibility
    Gieling, Emilie M.
    Wallenburg, Eveline
    Frenzel, Tim
    de Lange, Dylan W.
    Schouten, Jeroen A.
    ten Oever, Jaap
    Kolwijck, Eva
    Burger, David M.
    Pickkers, Peter
    ter Heine, Rob
    Bruggemann, Roger J. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 770 - 774
  • [62] Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function
    Gijsen, Matthias
    Elkayal, Omar
    Annaert, Pieter
    Van Daele, Ruth
    Meersseman, Philippe
    Debaveye, Yves
    Wauters, Joost
    Dreesen, Erwin
    Spriet, Isabel
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 53 - 62
  • [63] Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance Predictor
    Gijsen, Matthias
    Huang, Chao-Yuan
    Flechet, Marine
    Van Daele, Ruth
    Declercq, Peter
    Debaveye, Yves
    Meersseman, Philippe
    Meyfroidt, Geert
    Wauters, Joost
    Spriet, Isabel
    [J]. CRITICAL CARE MEDICINE, 2020, 48 (12) : E1260 - E1268
  • [64] Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment
    Gregoire, Nicolas
    Marchand, Sandrine
    Ferrandiere, Martine
    Lasocki, Sigismond
    Seguin, Philippe
    Vourc'h, Mickael
    Barbaz, Mathilde
    Gaillard, Thomas
    Launey, Yoann
    Asehnoune, Karim
    Couet, William
    Mimoz, Olivier
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (01) : 117 - 125
  • [65] Optimization of the treatment with beta-lactam antibiotics in critically ill patientsguidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et TherapeutiqueSFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et ReanimationSFAR)
    Guilhaumou, Romain
    Benaboud, Sihem
    Bennis, Youssef
    Dahyot-Fizelier, Claire
    Dailly, Eric
    Gandia, Peggy
    Goutelle, Sylvain
    Lefeuvre, Sandrine
    Mongardon, Nicolas
    Roger, Claire
    Scala-Bertola, Julien
    Lemaitre, Florian
    Garnier, Marc
    [J]. CRITICAL CARE, 2019, 23 (1)
  • [66] Is the standard dose of amoxicillin-clavulanic acid sufficient?
    Haeseker, Michiel
    Havenith, Thomas
    Stolk, Leo
    Neef, Cees
    Bruggeman, Cathrien
    Verbon, Annelies
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [67] Linezolid: a review of its properties, function, and use in critical care
    Hashemian, Seyed MohammadReza
    Farhadi, Tayebeh
    Ganjparvar, Mojdeh
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1759 - 1767
  • [68] Pharmacokinetic evaluation of piperacillin-tazobactam
    Hayashi, Yoshiro
    Roberts, Jason A.
    Paterson, David L.
    Lipman, Jeffrey
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (08) : 1017 - 1031
  • [69] Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically III Patients
    Heffernan, Aaron J.
    Sime, Fekade B.
    Kumta, Nilesh
    Wallis, Steven C.
    McWhinney, Brett
    Ungerer, Jacobus
    Wong, Gloria
    Joynt, Gavin M.
    Lipman, Jeffrey
    Roberts, Jason A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [70] Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance
    Hirai, Keita
    Ihara, Setsuko
    Kinae, Ayumi
    Ikegaya, Kenichi
    Suzuki, Masayuki
    Hirano, Keiko
    Itoh, Kunihiko
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 393 - 397